Amgen Inc. (AMGN) Fundamentals

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
SHARE INFORMATION
Market Cap$ 131,108,689,556
Shares Outstanding534,199,933
Float533,624,237
Percent Float99.89%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 7.04
Latest Fiscal Revenue$ 25,979,000,000
Latest Fiscal EPS$ 10.30
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 8.73
Dividend (5 Years)$ 10.76
Ex Dividend Date2022-05-16
Dividend Rate$ 7.76
Dividend Yield3.16%
Payment CashCash
HOLDERS
Institutions3,901
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months31,970,711
Institutional Holdings Percent174.1%
Institutional Sold Previous 3 Months65,746,219
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months380,490
Insider Holdings Percent0.6
Insider Sold Previous 3 Months95,187
Insider Shares Owned3,222,447
TRADING INFO
52 Week High$ 258.45
52 Week Low$ 198.64
52 Week High Change$ 4.58
21 Day Moving Average$ 242.8695
21 Day Extended Moving Average$ 242.6166
50 Day Moving Average$ 243.3331
50 Day Extended Moving Average$ 242.6089
200 Day Moving Average$ 224.6384
200 Day Extended Moving Average$ 234.9734
10 Day Average Volume4,391,259
20 Day Average Volume3,656,553
30 Day Average Volume3,508,136
50 Day Average Volume3,426,952
Alpha0.007087
Beta0.5661
Standard Deviation0.064968
R20.170260
7 Day Price Change$ 5.29
7 Day Percent Change2.2%
21 Day Price Change$ -0.05
21 Day Percent Change-0.02%
30 Day Price Change$ -9.83
30 Day Percent Change-3.85%
Month to Date Price Change$ -11.31
Month to Date Percent Change-4.41%
Quarter to Date Price Change$ 5.54
Quarter to Date Percent Change2.31%
180 Day Price Change$ 21.56
180 Day Percent Change9.63%
200 Day Price Change$ 38.00
200 Day Percent Change18.32%
Year to Date Price Change$ 24.15
Year to Date Percent Change10.91%

Amgen Inc. (AMGN) Key Ratios

PROFITABILITY
EBIT Margin29.4%
EBITDA Margin42.3%
Pre-Tax Profit Margin36.1%
Profit Margin Count21.87%
Gross Margin73.3%
Profit Margin TOT21.87%
INCOME STATEMENTS
Revenue$ 26,316,000,000
Revenue Per Share$ 49.2625
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-4.60
Total Debt To Equity40.20
Int Coverage6.40
Current Ratio1.40
Leverage Ratio10.30
Quick Ratio0.90
Long Term Debt To Capital0.98
VALUATION MEASURES
PE Ratio24.00
Enterprise Value$ 160,393,025,684
Price to Sales4.9821
Price to Free Cash78.60
PE High Last 5 Years78.10
Price To Book142.00
Price To Cash Flow14.80
PE Low Last 5 Years13.20
Price to Tangible Book-4.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.60
Invoice Turnover1.60
Assets Turnover0.40
Return Assets9.68
Return on Equity117.64
Return on Capital17.00

Amgen Inc. (AMGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORobert A. Bradway
Emplyoees24200
Last AuditUQ
CIK0000318154
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressOne Amgen Center Drive
Thousand Oaks, CA 91320-1799
Websitehttps://www.amgen.com
Facsimile+1 805 447-1010
Telephone+1 805 447-1000
Emailinvestor.relations@amgen.com
Your Recent History
NASDAQ
AMGN
Amgen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220702 05:55:18